⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STOK News
Stoke Therapeutics, Inc. Common Stock
MVP Ventures Deepens Ties With South Korean Investor Community as Managing Partner Weston Moyer Visits Seoul
globenewswire.com
NDLS
STOK
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16 th European Epilepsy Congress (EEC)
businesswire.com
STOK
BIIB
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
globenewswire.com
STOK
BIIB
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
businesswire.com
STOK
BIIB
Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors
prnewswire.com
BTAI
REGN
STOK
TCRX
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
globenewswire.com
STOK
BIIB
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16 th European Epilepsy Congress (EEC)
businesswire.com
STOK
BIIB
Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight
globenewswire.com
BIIB
HRMY
XNCR
AZN
LLY
PFE
REGN
NVS
TSLA
TAK
GSK
JNJ
UCB
BHF
PRAX
XENE
AQST
TNDM
INCY
MRK
ABBV
BMY
AMGN
GILD
VRTX
CRSP
EDIT
NTLA
SRPT
ALNY
EXAS
TEVA
AXSM
CYTK
INSM
KODK
LPCN
MNKD
NBIX
NCLH
ONCY
ORIC
PBYI
PEGA
PLRX
PRGS
QGEN
RGNX
ROST
RYAAY
SNOW
SWKS
SYK
TGT
TRMB
TXG
ULTA
VRSK
WDC
WVE
XOM
ZBRA
ZNTL
ZTS
STOK
IONS
MOMO
BBAR
CTXR
MBIO
GNS
NEON
OVID
BHVN
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
Form 8-K
sec.gov
STOK